FDA Approves Unknown Drug — HERITAGE PHARMA AVET

# FDA Approves Heritage Pharma Avet's ANDA Application Heritage Pharma Avet has received FDA approval for its Abbreviated New Drug Application (ANDA077663), expanding the company's generic pharmaceutical portfolio and positioning it to capture additional market share in the competitive generic drug sector. The approval enables Heritage Pharma Avet to manufacture and distribute a bioequivalent generic formulation, potentially offering cost savings to consumers while strengthening the company's presence in the generic medication marketplace.